SCHEMBL9749844

SCHEMBL9749844

COC(=O)CC(C)c1nsnc1OCC(O)CNC(C)C

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 4/20 0.47
ADRB1 P08588 4/20 0.47
ADRB3 P13945 2/20 0.43
OPRK1 P41145 1/20 0.42
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 1/20 0.42
PTGS1 P23219 1/20 0.41
SLC6A2 P23975 1/20 0.41
LMNA P02545 1/20 0.41
CNR1 P21554 1/20 0.41
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9749837 0.90 ADRB2 (0.42) ADRB2ADRB1ADRB3OPRK1MEN1
SCHEMBL10992310 0.88 ADRB2 (0.36) ADRB2ADRB1ADRB3OPRK1MEN1
SCHEMBL9749830 0.86 ADRB2 (0.52) ADRB2ADRB1ADRB3CYP1A2CYP2D6
SCHEMBL10992536 0.83 CYP1A2 (0.42) ADRB2ADRB1ADRB3CYP1A2CYP2D6
SCHEMBL10991811 0.82 ADRB1 (0.43) ADRB2ADRB1ADRB3CYP1A2CYP2D6
SCHEMBL9750357 0.80 CYP1A2 (0.34) ADRB2ADRB1ADRB3CYP1A2CYP2D6
SCHEMBL10982702 0.79 ADRB2 (0.44) ADRB2ADRB1ADRB3CYP1A2CYP2D6
SCHEMBL9749867 0.79 ADRB2 (0.56) ADRB2ADRB1ADRB3OPRK1MEN1
SCHEMBL10993872 0.79 ADRB2 (0.34) ADRB2ADRB1ADRB3OPRK1MEN1
SCHEMBL9749921 0.77 ADRB1 (0.47) ADRB2ADRB1ADRB3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0131006-B1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-06-10 EP disclosed
EP-0131006-A4 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES. AMERICAN HOSPITAL SUPPLY CORP (US) 1985-06-06 EP disclosed
US-4508725-A BETA-ADRENERGIC BLOCKING AGENTS; GLAUCOMA TREATMENT AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1985-04-02 US disclosed
EP-0131006-A1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES. AMERICAN HOSPITAL SUPPLY CORP (US) 1985-01-16 EP disclosed
WO-1984002525-A1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES AMERICAN HOSPITAL SUPPLY CORP (US) 1984-07-05 WO disclosed